All News

A cancer survivor, who is in her 14th year of remission, recalls how image visualization complemented her cancer treatment and suggests the practice may help others.

With winter upon us, a caregiver discusses how the end of life is akin to the cycle of seasons and how hospice does not have to be a challenging hurdle.

Onivyde may offer patients with small cell lung cancer whose disease has progressed after initial chemotherapy a new treatment option, according to updated study results.

Treatment with immuno-oncology therapies induces better responses in younger patients with small cell lung cancer, compared to older patients.

Though there are currently few approved treatments for advanced, pre-treated small cell lung cancer (SCLC), this patient population may have a safe and effective new option in apatinib, according to updated data from a prospective phase 2 study.

Treatment with Opdivo (nivolumab) in combination with the novel therapy BMS-986012 demonstrated a median overall survival of 18.7 months and a median progression-free survival of 2.1 months among a group of patients with relapsed/refractory small cell lung cancer.

Here are 4 tips from a fellow cancer survivor on how to push through the dark COVID-19 winter ahead.

From a urologist with a terminal cancer diagnosis receiving tickets to the 2021 Super Bowl to see his favorite quarterback Tom Brady compete for a seventh championship, to Indiana Pacers guard Caris LeVert undergoing surgery for renal cell carcinoma, here’s what’s happening in the cancer landscape this week.

In a survey conducted by the Cancer Support Community, 33% of patients with lung cancer reported they were somewhat or not at all involved in the decision-making process, and 66% were not as knowledgeable about their treatment options as needed to make this decision.

The FDA’s fast track designation for toripalimab to treat patients with mucosal melanoma may lead to an accelerated approval of the novel therapy.

Skating has been an invaluable part of my life, and one that taught me a crucial lesson for handling life with cancer.

In this episode of the “CURE Talks Cancer” podcast, we spoke with a patient who is receiving treatment for grade 3 triple-negative breast cancer. We talk about how a nurse’s question during a routine physical “saved her life”, and a kindness challenge she started to help lift her up during the dark days of treatment.

Here is a list of some recent trials that launched within the cancer space in January.

Avastin, in combination with carboplatin plus paclitaxel (types of chemotherapy), improved progression-free survival and overall survival compared with those who received chemotherapy alone for patients with untreated advanced mucosal melanoma.

There are multiple treatment patients for patients with cholangiocarcinoma, here's what you need to know about them.

In a phase 2 study of 24 patients with biliary cancer, Aliqopa in combination with Gemzar and chemotherapy led to a six-month progression-free survival rate of 51% with a median overall survival of 13.7 months.

COVID-19 has robbed us of the physical ways we remember important milestones on the cancer journey and the physical ways we need to mourn.

Some patients receiving opioids to treat cancer-related pain may be more susceptible than others to engage in non-medical opioid use.

Tecentriq with carboplatin and etoposide led to a median overall survival rate of 12.3 months versus 10.3 months in those assigned placebo, carboplatin and etoposide, although the death rate was high at a median follow-up of 22.9 months.

On social media, CURE® recently asked its readers to share what they wished people without cancer could understand about their experiences with the disease.

A cancer survivor writes about how he, like many, was blindsided by his diagnosis and what it was like to receive treatment for a rare disease: penile cancer.

Even after surgery for breast cancer women can still feel empowered and own their sense of self-worth.

Regular aspirin use may increase survival in patients with bladder and breast cancer.

At three years, overall survival in men with nonmetastatic, castration-resistant prostate cancer treated with Nubeqa was 83% compared with 77% in those who received placebo.

People recently diagnosed with cancer may be at an increased risk of contracting COVID-19 and experiencing worse outcomes than those who have never had a cancer diagnosis. The association was heightened in Black patients.

The National Comprehensive Cancer Network (NCCN) recommends that patients receiving active cancer treatment get the COVID-19 vaccine.

A simple quote reminds a cancer survivor of what is important for every one of us to remember.

Combination treatment with Opdivo and Yervoy may have better overall survival rates for patients with metastatic uveal melanoma.